Admelog and Taztia XT

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.

A single case report suggests that diltiazem may decrease the hypoglycemic effect of insulin. The mechanism of interaction is unknown. Diltiazem 180 mg/day reportedly had no effect on glucose levels in normal subjects. In addition, diltiazem 240 to 360 mg/day had no significant effects on glucose control in 23 hypertensive patients with Type II diabetes. While no special precautions appear to be necessary, patients may consider monitoring blood glucose more closely during the first few days or weeks of diltiazem therapy until glucose control is assured.

Admelog

Generic Name: insulin lispro

Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog

Synonyms: n.a.

What is Admelog?

Taztia XT

Generic Name: diltiazem

Brand name: Cardizem CD, Cartia XT, Dilt-XR, Diltia XT, Taztia XT, Tiazac, Cardizem, Dilacor XR, Dilt-CD, Diltzac, Matzim LA, Tiazac, Cardizem LA, Tiazac Extended Release Capsules

Synonyms: n.a.

What is Taztia XT?